FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to medicine, pharmacology. Use of buspirone or a pharmaceutically acceptable salt thereof for the treatment of functional dizziness, in particular persistent postural percutaneous vertigo (PPPD), postural phobic instability (PPV), chronic subjective dizziness (CSD), and a pharmaceutical composition of the same use, including buspirone or said salt.
EFFECT: clinically optimal speed of the onset of the therapeutic effect of buspirone, the possibility of treating functional dizziness independent of depressive and anxious conditions.
17 cl, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BUSPIRON COMBINATION FOR TREATMENT OF FAINTNESS | 2018 |
|
RU2682966C1 |
| COMBINATION OF ACETYLLEICINE FOR TREATMENT OF DIZZINESS | 2017 |
|
RU2680413C1 |
| CARBAMATE COMPOUNDS FOR USING IN PROPHYLAXIS OR TREATMENT OF ANXIETY DISORDERS | 2002 |
|
RU2292881C2 |
| METHOD OF TREATING PATIENTS WITH BENIGN PAROXYSMAL POSITIONAL DIZZINESS WITH INJURY OF FRONT SEMICIRCULAR DUCT | 2012 |
|
RU2487693C1 |
| METHOD OF TREATING PATIENTS WITH BENIGN PAROXYSMAL POSITIONAL DIZZINESS WITH INVOLVEMENT OF A POSTERIOR SEMICIRCULAR CANAL | 2018 |
|
RU2694997C1 |
| METHOD OF THE PANIC DISORDER FORMING RISK PREDICTING AT THE EARLY STAGE OF DISEASE | 2016 |
|
RU2644309C1 |
| METHOD FOR PHYSIOTHERAPEUTIC TREATMENT OF VERTIGO | 2016 |
|
RU2637618C1 |
| METHOD OF REDUCING ANXIETY THROUGH MANUAL MANIPULATION | 2023 |
|
RU2814746C1 |
| METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF APHOBAZOLUM ANXIOLYTIC IN PATIENTS WITH ANXIETY DISORDERS | 2019 |
|
RU2736391C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENT BENIGN PAROXYSMAL POSITIONAL VERTIGO OF POSTERIOR SEMICIRCULAR CANAL | 2017 |
|
RU2634037C1 |
